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Microglia,  the  CNS  resident  macrophages,  and  astrocytes,  the  most  abundant  glial  cell  population,  are
both implicated  in brain pathologies  and  can exhibit  a  pro-inflammatory  phenotype.  Microglial  cells  are
known to rapidly  and  strongly  react  to brain  insults.  They  will  promote  astrocyte  activation  and  may
lead  to a vicious,  self-perpetuating  cycle  of  chronic  inflammation.  To  obtain  a better  understanding  of
the  individual  role  of  both  cell types,  primary  cells  are  frequently  used  in  in vitro  studies,  but the  purity
of  specific  cell  cultures  remains  rarely  investigated.  The  aim of  this  study  is  to determine  the  effect  of
specific  removal  of microglial  cells  on the  inflammatory  properties  of  different  glial cultures.  Here,  the
removal of microglial  contamination  from  mixed  glial  cultures  to obtain  astrocyte-enriched  cultures
was  achieved  using  a  magnetic  cell  sorting  approach.  Compared  to mixed  cultures,  we  clearly  showed
that these  enriched  cultures  are  only  weakly  activated  by pro-inflammatory  agents  (lipopolysaccharide,
interferon-!  or beta-amyloid  peptide).  This  finding  was  confirmed  using  twice-sorted  astrocyte-enriched
cultures  and  microglia-free  cultures  composed  of neurosphere-derived  astrocytes.  Thus,  we  present  evi-
dence  that  the magnitude  of the  pro-inflammatory  response  is  linked  to  the  percentage  of microglia  in
cultures. Due  to  their  high  reactivity  to various  insults  or pro-inflammatory  stimuli,  microglia-derived
effects  could  be credited  to astrocytes  in  mixed  glial  cultures.  Therefore,  we  highlight  the  importance
of  monitoring  the presence  of  microglia  in glial  cultures  since  they  can  affect  the  interpretation  of  the
results,  especially  when  inflammatory  processes  are  studied.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
In the central nervous system (CNS), glial cells have supportive
roles for neurons but also act as the resident immune system cells,
engaging several inflammatory processes to defend the brain from
pathogens and helping it to recover from stress and injury (Farfara
et al., 2008). However, in brain pathologies, chronic glial activation
is a common event, which could promote a progressive dysfunc-
tion and loss of neurons in the CNS. Astrocytes and microglia are
both glial cells whose physiological roles and responses upon acti-
vation are quite distinct. Astrocytes, the most abundant glial cell
population, are essential for brain homeostasis and neuronal func-
tion. Although astrocytes play a significant role in maintaining
normal CNS functions, after injury these glial cells may  exert patho-
physiological actions leading to neuronal damage (Sofroniew and
Vinters, 2010). Microglial cells are the resident macrophages in
the CNS (Beutner et al., 2010; Hanisch and Kettenmann, 2007;
Dobrenis, 1998). These cells represent the first line of defense
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against pathogens or brain tissue injury. In their activated state,
they have beneficial functions essential for neuron survival (Ekdahl
et al., 2009). On the other hand, microglial overactivation can give
rise to progressive neurotoxic consequences (Lull and Block, 2010;
Block et al., 2007). Microglial activation can also promote astrocyte
activation, which in turn can further activate microglia, thus possi-
bly leading to a vicious cycle of overactivation that may  contribute
to a chronic inflammatory state, with continuously increasing pro-
duction of pro-inflammatory mediators (Liu et al., 2011; Vallejo
et al., 2010; Saijo et al., 2009; Henze et al., 2005; Zaheer et al.,
2002).
In vitro experiments using near-pure glial cultures are nowadays
widely used in order to avoid heterogeneous cell–cell interactions
and to characterize cell-specific signaling pathways. Thus, diverse
methods have been developed for cell separation and purification
(for review, see Dainiak et al., 2007). Actually, the most widely used
technique for harvesting a single glial population is dependent on
a mechanical shake-off method (Floden and Combs, 2007), but this
is wrought with issues as it often still leaves a mixture of differ-
ent glial cells. Newer techniques are based on physical criteria like
size, shape, and density. They include filtration and centrifugation
approaches (Fuss et al., 2009; Lara and Chalmers, 2005; Graham,
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http://dx.doi.org/10.1016/j.jneumeth.2012.03.010
Author's personal copy
60 S. Losciuto et al. / Journal of Neuroscience Methods 207 (2012) 59– 71
2001), and also affinity approaches based upon biochemical cell
surface and biophysical characteristics (Cho et al., 2010). Other
approaches are the use of anti-mitotic agents to inhibit microglial
growth in primary astrocyte cultures (Hamby et al., 2006a; Solenov
et al., 2004) or the differential adherence of various glial cells on cell
culture plates (Jana et al., 2007). In this study, we used a more recent
technique for primary microglia isolation (Marek et al., 2008). Based
on an antigen–antibody-mediated magnetic cell sorting system
using CD11b MicroBeads, this technique allowed to rapidly obtain
pure astrocyte cultures after microglia depletion.
Our work further stresses the growing consensus that great
care must be taken when using glial cultures to assess astrocyte
responses to inflammatory stimuli, as even small levels of microglia
will have a major influence on the observed effects. Therefore,
without a rigorous quality check, microglia-derived effects could
be attributed to astrocytes. Due to their high pro-inflammatory
capacities, microglia rapidly detect and strongly respond to a large
number of stimuli. The presence of microglia must not be underes-
timated and great caution should be taken when preparing primary
glial cultures (Saura, 2007). Thus, we investigated whether classi-
cal pro-inflammatory stimuli, such as LPS, IFN! or beta-Amyloid
(A") peptide, were able to activate different types of glial cell
cultures: mixed glial cultures (called MGC1), astrocyte-enriched
cultures (called AEC-M1 and AEC-M2), neurosphere-derived astro-
cyte cultures, and primary microglia cultures. We  provide clear
evidence that the magnitude of the pro-inflammatory response was
dependent on the proportion of contaminating microglial cells in
our cultures.
2. Materials and methods
2.1. Mixed glial cultures
Mixed glial cell cultures were prepared from newborn C57BL/6
mouse brains (Harlan, The Netherlands) (Fig. 1). Briefly, after care-
fully removing meninges and large blood vessels, the brains were
pooled and then minced in cold phosphate-buffered saline (PBS)
solution. The dissociation was completed by a 10 min  incubation
in 2 mM-cold EDTA. After washes and centrifugations, the cells
were plated and grown in complete medium (Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 100 U/ml penicillin and 100 #g/ml streptomycin) at 37 ◦C in
a humidified atmosphere containing 5% CO2. The culture medium
was changed after 3 days of culture. After 8–10 days, mixed glial cul-
tures (passage 0 or P0) had reached confluence, and microglia were
detached by a 30 min  shaking on a rotary shaker at 200 rpm at 37 ◦C.
Detached cells, mainly microglia (Iba1-positive cells >95%) were
then plated in the same medium (astrocyte-conditioned medium)
in a humidified atmosphere containing 5% CO2 and were ready-to-
use 24 h later. Oligodendrocytes were subsequently detached from
the mixed glial cultures (P0) by 2 days of washing and shaking steps
on a rotary shaker at 200 rpm at 37 ◦C in a humidified atmosphere
containing 5% CO2. Afterwards, the culture medium was removed
and mixed glial cultures were washed with PBS and incubated with
0.05% trypsin/0.53 mM  EDTA at 37 ◦C for 5 min. Then, the trypsin
was inactivated by the addition of complete medium and the cellu-
lar suspension was centrifuged at 300 × g at 4 ◦C for 10 min. The cell
pellet was resuspended in complete medium and then plated. After
6–7 days, mixed glial cultures (P1), called MGC1, had reached con-
fluence. To detach residual microglia and oligodendrocytes, these
cultures were shaken again for 2 days with 3 washings per day
on a rotary shaker at 200 rpm at 37 ◦C in a humidified atmosphere
containing 5% CO2. Finally, fresh complete medium was added and
these MGC1 were ready-to-use. Cell culture products were pur-
chased from Invitrogen (Scotland).
2.2. Magnetic cell sorting for astrocyte-enriched cultures
As indicated in Fig. 1, mixed glial cultures (P1) or MGC1, obtained
after the trypsinization step (described above), were further
worked-up by magnetic cell sorting (MACS). After trypsinization
and centrifugation at 300 × g at 4 ◦C for 10 min, the cell pellet was
resuspended in a separation buffer containing PBS, pH 7.2, 0.5%
bovine serum albumin (BSA) and 2 mM EDTA. The cell suspension
was centrifuged at 300 × g at 4 ◦C for 10 min. Following manu-
facturer’s instruction, 1 × 107 cells were resuspended in 90 #l of
buffer and 10 #l of CD11b MicroBeads (MicroBeads conjugated to
monoclonal rat anti-mouse CD11b antibody, Miltenyi Biotec, The
Netherlands). The suspension was incubated at 4 ◦C for 20 min  with
gentle mixing after 10 min. During the incubation step, the CD11b-
positive cells, microglia, were magnetically labeled with CD11b
MicroBeads. Then, cells were washed with the separation buffer
and centrifuged at 300 × g at 4 ◦C for 10 min. The cellular pellet
was resuspended in 500 #l of separation buffer for 1 ×108 cells.
A LS column (Miltenyi Biotec) was  fixed into the MidiMACS mag-
netic separation unit (Miltenyi Biotec) and washed with 3 ml  of
separation buffer. The cell suspension was  applied on the column
and three washings of 3 ml  of separation buffer were performed
with the same collecting tube. The unlabeled-cell fraction, mainly
astrocytes, was  passed through the column. The LS column was
then detached from the magnetic separator and flushed with 5 ml
of separation buffer. This step was performed to collect CD11b-
positive cells. Both cellular fractions were centrifuged at 300 × g at
4 ◦C for 10 min. The astrocyte-enriched fraction (called AEC-M1),
corresponding to the CD11b-negative fraction, was resuspended
in complete medium before plating. After 6–7 days, AEC-M1 were
confluent and ready-to-use. The CD11b-positive fraction, microglia,
were plated in astrocyte-conditioned medium and were ready-to-
use 24 h later.
In order to vastly reduce microglial contamination, a second
magnetic cell sorting (as previously described) was practiced from
AEC-M1 to obtain even purer astrocyte cultures (AEC-M2). After
6–7 days, AEC-M2 were confluent and ready-to-use.
2.3. Neurosphere-derived astrocyte cultures
Primary cultures of neurospheres were obtained from embry-
onic murine neural stem cells derived from the subventricular
zone (SVZ) of embryonic day 14 (E14) C57BL/6 mouse embryos
as described previously (Grandbarbe et al., 2003). The SVZ of
embryonic brain was extracted, triturated mechanically with a
fired-narrowed Pasteur pipette. Dissociated cells were centrifuged
at 300 × g for 5 min, washed once and then plated in noncoated
6-well plates until neurospheres appeared. Neurospheres were cul-
tured in Neurobasal-A medium supplemented with 1% B27 without
vitamin A, 2 mM l-glutamine, 100 U/ml penicillin, 100 #g/ml strep-
tomycin and 20 ng/ml recombinant mouse Epidermal Growth
Factor (rmEGF). These neurospheres were passaged by chemical,
non-enzymatic dissociation every 5–6 days and reseeded as single
cells at a density of 1 × 106 cells/ml. Neurospheres were differen-
tiated into astrocytes by plating them on poly-l-ornithine coated
flasks in DMEM containing 10% FBS and 1% antibiotics (Crocker
et al., 2008). The culture medium was renewed after 3 days of
differentiation and subsequently once a week. After 6 weeks of
differentiation, the cells were considered to be completely differ-
entiated into mature astrocytes.
2.4. Cell treatments
All treatments were applied on confluent cultures. Lipopolysac-
charide (LPS 055:B5 from Escherichia coli,  Sigma, Belgium) was
added at 1 #g/ml on mixed and enriched glial cultures but at
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Fig. 1. Schematic drawing representing the cell isolation process.
only 1 ng/ml on primary microglia, since a higher concentration
is deleterious for these cells. IFN! (Hycult Biotechnology, The
Netherlands) was used at 50 U/ml. The A"(1–42) peptide (Bachem,
Germany) was initially dissolved to 5 mM in DMSO, separated into
aliquots in sterile tubes and stored at −20 ◦C. The stock aliquot was
diluted to 0.5 mM in DMEM containing 1% antibiotics (100 U/ml
penicillin and 100 #g/ml streptomycin). This A" preparation was
added directly to cultures at a final concentration of 5 #M.
2.5. Cellular viability assay
Mitochondrial function was assessed as an index of cellular via-
bility using the MTT  method. This assay measures the ability of
mitochondrial dehydrogenases to convert 3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide (MTT) to colored insoluble
formazan. Cells were seeded on 48-well plate at an initial density
of 2 × 105 cells/well. After treatment, cells were incubated for 3 h
at 37 ◦C with MTT  (0.35 mg/ml) diluted in PBS. Then, the medium
was removed, and cells were lysed by addition of 100% DMSO.
Absorbance was  measured at 540 nm using a microplate reader
(TECAN, Austria). Viability was  estimated from the absorbance of
treated versus untreated cells.
2.6. Flow cytometry
The MACS-based sorting of microglial cells from mixed glial
cultures was  assessed by flow cytometry. Cells were harvested by
trypsinization, centrifuged and resuspended in 3% BSA in PBS. For
intracellular markers, cells were previously fixed and permeabi-
lized in PBS-paraformaldehyde 4% and 0.01% of Triton X100 at 4 ◦C
for 30 min. After a washing step, cells were incubated for 45 min
with primary antibodies: rabbit anti-Iba1 (1:100, Biocare Medi-
cal, USA) or Cy3-labeled mouse anti-GFAP (1:800, Sigma, Belgium).
Then, cells were stained with Cy2-conjugated anti-rabbit (1:1000,
Jackson ImmunoResearch, England). The cells were washed in PBS
after each incubation step. As negative controls, the same staining
Author's personal copy
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procedure was repeated in parallel with the corresponding iso-
type control antibodies (Jackson ImmunoResearch). The samples
were analyzed on a flow cytometer (FACS Canto, Becton Dickinson)
and data analysis was performed using WinMDI software (Scripps
Research Institute, USA).
2.7. Immunofluorescence
Cells were cultured on poly-l-ornithine coated coverslips for
one week and then fixed with paraformaldehyde (4% in PBS) for
20 min  at room temperature, and permeabilized for 5 min  in PBS
containing 0.3% Triton X100. Following 3 washings in PBS, the
blocking step was realized with 3% BSA in PBS at room temper-
ature for 30 min. The cells were then incubated overnight at 4 ◦C
with Cy3-labeled mouse anti-GFAP (1:800, Sigma) and rabbit anti-
Iba1 (1:300, Biocare Medical). After washing steps with PBS, cells
were incubated with Cy2-conjugated anti-rabbit (1:1000, Jackson
ImmunoResearch) at room temperature for one hour. The cells
were washed 3 times with PBS, and stained with DAPI (1:5000)
for 5 min. Cells were then washed, mounted with Fluoromount
G (SouthernBiotech, USA), and observed under a LSM 510 META
inverted confocal microscope (Carl Zeiss Micro Imaging, Göttingen,
Germany) at a 40-fold magnification.
2.8. Real-time reverse transcription-polymerase chain reaction
(RT-PCR) analysis
Total RNA was isolated from glial cultures using the InvisorbTM
Spin Cell RNA Mini Kit (Invitek, Germany) according to the man-
ufacturer’s protocol. Total RNA was recovered in elution buffer
and quantified from the absorbance at 260 nm. The purity was
verified by spectrophotometry (absorbance ratio at 260 nm versus
280 nm). The RNA electrophoresis Experion system (Bio-Rad, CA)
was used to confirm the absence of RNA degradation and genomic
contamination. Complementary DNA (cDNA) was synthesized from
RNA samples using 0.5 #g of total RNA and the ImProm-II Reverse
Transcription System with 0.5 #g/reaction oligo(dT) as primer.
The RNA and oligo(dT) were denaturated at 70 ◦C for 5 min  and
immediately chilled on ice for at least 5 min. The reverse tran-
scription reaction was performed in a total volume of 40 #l by
mixing 2 #l ImProm-IITM reverse transcriptase, 25 mM MgCl2,
0.5 mM of each dNTP, and 1 #l of Recombinant RNasin® Ribonu-
clease inhibitor in ImProm-II 5X Reaction Buffer. Samples were
incubated for 1 h at 42 ◦C and 15 min  at 70 ◦C to inactivate
the reverse transcriptase. A 1 #l aliquot of cDNA was  used for
each amplification by real-time PCR and added to the incuba-
tion mixture containing 8 #l of 2X iQTM SYBR Green Supermix,
0.8 #l of each 12.5 #M optimized forward and reverse primers
in a final volume of 20 #l. Primer sequences (Table 1) were
designed using the Beacon Designer Software (Bio-Rad). PCR anal-
ysis were performed on a Bio-Rad iCycler (iQ5 Real-Time PCR
Detection System) using a 2-stage program provided by the man-
ufacturer: 3 min  at 95 ◦C followed by 40 cycles, consisting of
denaturation at 95 ◦C for 10 s and annealing/extension at a tem-
perature between 52.5 ◦C and 60.5 ◦C for 30 s. The change of
reporter fluorescence from each reaction tube was  monitored.
Analysis of gene expression was performed using the compara-
tive threshold cycle (Ct) method. The threshold cycle of each gene
was determined as PCR cycles at which an increase in reporter
fluorescence above a baseline signal was observed (Table 2).
The target gene was normalized to the endogenous reference
gene, Rpl27 (a housekeeping gene coding for a ribosomal pro-
tein). The mRNA expression fold change was calculated using
the expression 2−ddCt, where ddCt = (Ct,target− Ct,Rpl27)treated sample
− (Ct,target− Ct,Rpl27)control sample.
Table 1
Sequences of the different real-time PCR primers.
Target gene
(accession number)
Sequence (5′–3′) Product size
Nos2 (NM 010927) f: AGCCCTCACCTACTTCCTG
r: CAATCTCTGCCTATCCGTCTC
100 bp
Ptgs2 (NM 011198) f: GCCTGGTCTGATGATGTATGC
r: GAGTATGAGTCTGCTGGTTTGG
124 bp
Tnf  (NM 013693) f: GGTTCTGTCCCTTTCACTCAC
r: TGCCTCTTCTGCCAGTTCC
107 bp
Il1" (NM 008361) f: GCTTCAGGCAGGCAGTATC
r: AGGATGGGCTCTTCTTCAAAG
133 bp
Il6  (NM 031168) f: ACCGCTATGAAGTTCCTCTC
r: CTCTGTGAAGTCTCCTCTCC
117 bp
Ccl2 (NM 011333) f: ACTCACCTGCTGCTACTCATTC
r: GCTTCTTTGGGACACCTGCTG
97 bp
Ccl3 (NM 011337) f: TTTGAAACCAGCAGCCTTTG
r: CAGGTCAGTGATGTATTCTTGG
114 bp
Gfap (NM 010277) f: GGTTGAATCGCTGGAGGAG
r: CTGTGAGGTCTGGCTTGG
131 bp
Itgam (NM 008401) f: TGGACGCTGATGGCAATACC
r: GGCAAGGGACACACTGACAC
94 bp
Aif1 (NM 019467) f: TTCCCAAGACCCACCTAG
r: TCCTCATACATCAGAATCATTC
142 bp
Rpl27 (NM 011289) f: ACATTGACGATGGCACCTC
r: GCTTGGCGATCTTCTTCTTG
111 bp
All reagents for reverse transcription and real-time PCR were
obtained from Promega (CA) and Bio-Rad, respectively.
2.9. Measurement of pro-inflammatory mediator release
Cells were seeded on 6-well plates at an initial density of
105 cells/well. After 6–7 days, cultures were confluent and ready-
to-use. The release of nitrite, a stable metabolite of nitric oxide (NO),
was measured after 24 and 48 h of LPS, IFN! and A" exposure.
The concentration of nitrite was determined in culture super-
natants by the Griess assay. The production of prostaglandins E2
(PGE2) and TNF$ was measured after 24 h of LPS, IFN! and A"
exposure. PGE2 and TNF$ release were measured in the medium
of the different cultures with a commercially available Enzyme
ImmunoAssay kit (Assay Designs, USA), and a sandwich Enzyme
Linked ImmunoSorbent Assay (R&D Systems, USA), respectively.
The protein content was determined using the Dye Reagent (Bio-
Rad) by measuring the absorbance at 595 nm,  using bovine serum
albumin standards.
2.10. Statistical analysis
For comparison of means between two  different treatments, sta-
tistical analysis was done by Student’s t-test (two-sample assuming
equal variances). For comparison of multiple treatments, results
were analyzed by an ANOVA followed by a Fisher’s exact test.
Differences between groups were considered as significant when
p-values were less than 0.05. Results are expressed as mean ± SEM
from at least three independent experiments.
3. Results
Following the experimental procedure described in Fig. 1,
we have prepared mixed glial cultures (P0) from the brains of
newborn mice. From these cultures, we  were able to prepare
other glial cultures, such as mixed glial cultures (MGC1), but
also astrocyte-enriched cultures (AEC-M1), twice-sorted astrocyte-
enriched cultures (AEC-M2) and microglial cultures. In this study,
we have also generated microglia-free cultures composed of
neurosphere-derived astrocytes.
Author's personal copy
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Table  2
Threshold cycle (Ct) value of the target genes in the different cultures.
Target gene (accession number) MGC1 AEC-M1 Neurosphere-derived astrocytes Primary microglia
Nos2 (NM 010927) 36.0 36.0 36.0 37.0
Ptgs2 (NM 011198) 28.0 27.5 33.5 30.0
Tnf  (NM 013693) 29.0 36.0 34.5 26.5
Il1" (NM 008361) 30.5 35.5 36.5 29.0
Il6  (NM 031168) 31.5 31.5 37.0 35.0
Ccl2  (NM 011333) 25.0 26.5 28.0 25.0
Ccl3  (NM 011337) 27.0 35.0 31.5 22.0
Gfap  (NM 010277) 21.0 21.0 20.5 –
Itgam (NM 008401) 29.2 34.4 36.0 22.6
Aif1  (NM 019467) 24.6 30.8 38.2 21.8
Rpl27 (NM 011289) 20.0 20.5 20.5 20.0
3.1. Analysis of the different glial cell culture preparations
Immunocytochemistry analysis revealed that the number of
microglial cells (Iba1-positive cells) in MGC1 was  much higher
compared to the ones contained in AEC-M1 (Fig. 2). Mouse astro-
cytes obtained by this separation process showed typical astrocyte
morphology as well as astrocytic marker expression (GFAP), which
was slightly lower than in MGC1. In both cultures, some cells were
negative for both Iba1 and GFAP markers. Furthermore, quantita-
tive data have been obtained by FACS analysis (Fig. 3). As shown in
Fig. 3A, a MACS separation increased the GFAP-positive cells from
about 60% in MGC1 to 70% in AEC-M1. The percentage of microglial
cells (Iba1-positive cells) has also been determined in both cul-
tures. Before cell sorting separation, Iba1-positive cells represented
9–10% of the culture (Fig. 3B), whereas Iba1-positive cell number
decreased to 1–1.5% of the total cells in enriched cultures (Fig. 3C).
Cell sorting by CD11b MicroBeads was used to obtain astrocyte-
enriched cultures, but also microglial cultures (>95% Iba1-positive
cells, data not shown).
3.2. Effects of pro-inflammatory stimuli: assessment of mRNA
levels
In order to evaluate the consequences of the presence of
microglial cells in our astrocyte cultures, pro-inflammatory condi-
tions were induced by treating MGC1 and AEC-M1 with LPS, IFN!
and A". Pro-inflammatory gene expressions were assessed by real-
time PCR (Fig. 4).
In MGC1, a 6 h LPS exposure strongly induced the expression
of Nos2 (Fig. 4A), Ptgs2 (Fig. 4B), Tnf (Fig. 4C), Il1" (Fig. 4D)  and
Il6 (Fig. 4E) as well as Ccl2 and Ccl3 chemokines (data not shown).
In AEC-M1, where the percentage of microglial cells was about 10-
fold lower than in MGC1, the expression of these pro-inflammatory
genes was  much lower compared to mixed culture responses: Nos2
(−90%), Ptgs2 (−85%), Tnf (−95%), Il1" (−97%), Il6 (−95%), Ccl2
(−50%, data not shown) and Ccl3 (−90%, data not shown).
IFN! and A" were less potent than LPS in both glial cultures,
but their effects were still different between MGC1 and AEC-M1
cultures. In MGC1, IFN! and A" induced Nos2 expression (Fig. 4F)
Fig. 2. Astrocyte and microglial cells in cultures. MGC1 and AEC-M1 were labeled with anti-GFAP antibody (red) in combination with the microglial marker Iba1 (green) and
counterstained with nuclear stain DAPI (blue). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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Fig. 3. Quantitative assessment of astrocyte and microglia populations by flow cytometry. The different glial cell populations were immunostained for flow cytometry
analysis.  GFAP (A) and Iba1-positive cells (B and C) were determined in both MGC1 (green events) and AEC-M1 (red events). For negative control (grey events), the same
staining procedure was  repeated with the secondary antibodies alone. Data analysis was performed using WinMDI software (Scripps Research Institute, USA). This is a
representation of one out of three experiments. All experiments showed similar profiles. (For interpretation of the references to color in this figure legend, the reader is
referred to the web  version of this article.)
by respectively 25-fold and 5-fold compared to the control level. On
the contrary, after magnetic separation, an IFN! exposure induced
lower Nos2 expression (4.5-fold), whereas A" had no effect on
it. In both conditions, Ptgs2 up-regulation (Fig. 4G) was similar.
Control expression levels of Tnf and Il1" (respectively Fig. 4H and
I) were higher in MGC1 due to increased basal expression lev-
els in microglia compared to astrocytes (Table 2). Thus, in MGC1,
IFN! and A" up-regulated Tnf by respectively 4.4-fold and 2-fold
(Fig. 4H). A" also increased Il1" expression (4-fold) contrary to
IFN!, which decreased Il1" expression (−20%). In AEC-M1, these
two pro-inflammatory compounds had different effects on the
expression of Tnf and Il1".  An IFN! exposure up-regulated Tnf
expression by 1.6-fold whereas A" had no effect. However, an A"
exposure up-regulated Il1" expression (2-fold induction) whereas
IFN! had no effect. IFN! and A" also induced a higher Il6 overex-
pression in MGC1 compared to AEC-M1 (Fig. 4J).
3.3. Comparison with neurosphere-derived astrocyte cultures
Neurosphere-derived astrocytes are considered as pure astro-
cytes. In response to an inflammatory stimulus (Fig. 5),
neurosphere-derived astrocytes reacted to TNF$ (data not shown)
and IFN! exposure. The presence of IFN! increased gene expres-
sion levels of Nos2, Ptgs2, Tnf and Il6 (respectively Fig. 5A–D)
but, in contrast to AEC-M1 cultures, LPS exposure did not increase
Nos2, Tnf, and Il6 expression. Moreover, a LPS treatment induced
a little increase of COX2 expression (2.2-fold). After IFN! and A"
treatments, the activation profile observed in neurosphere-derived
astrocytes was the same than the one found in AEC-M1. How-
ever, Il1" expression was not detectable in neurosphere-derived
astrocytes. In these conditions, the Gfap expression level was not
modulated by pro-inflammatory activations (Fig. 5E).
3.4. Comparison with primary microglia cultures
Compared with MGC1 and AEC-M1, primary mouse microglia
were highly sensitive to LPS (1 ng/ml), IFN! (50 U/ml) and A"
(5 #M)  exposures (Table 3). As expected, primary microglia showed
Table 3
Pro-inflammatory phenotype in primary microglia.
Target genes LPS IFN! A"
Nos2 22,737.9 ± 1932.8 41.9 ± 5.8 11.2 ± 2.2
Ptgs2 3008.3 ± 240.0 37.3 ± 3.6 28.5 ± 3.8
Tnf 1986.1 ± 253.6 5.7 ± 1.6 15.1 ± 2.1
Il1" 3482.8 ± 214.2 0.2 ± 0.04 20.7 ± 1.1
Ccl2 636.7 ± 54.2 12.3 ± 0.3 3.3 ± 0.5
Ccl3 101.4 ± 11.3 0.2 ± 0.03 7.5 ± 0.8
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Fig. 4. Evaluation of pro-inflammatory gene expressions. Pro-inflammatory gene Nos2 (A and F), Ptgs2 (B and G), Tnf (C and H), Il1" (D and I) and Il6 (E and J) expressions
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independent experiments). *p < 0.05, significantly different from control; #p < 0.05, significantly different between MGC1 and AEC-M1.
a much stronger inflammatory response than any of the other cell
populations. The three stimuli induced high expression levels of
Nos2, Ptgs2, Tnf as well as the Ccl2 chemokine. However, an IFN!
exposure reduced Il1" and Ccl3 expression in contrast to LPS and
A" treatments.
3.5. Effects of pro-inflammatory stimuli: assessment of
inflammatory protein release
As a result of Nos2, Ptgs2 and Tnf up-regulation, nitrites, PGE2
and TNF$ releases increased significantly after treatments in MGC1
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expressions as well as Gfap expression (E) were determined in neurosphere-derived
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different from control.
(Fig. 6). The production of these pro-inflammatory compounds was
higher under LPS conditions compared to IFN! or A" exposures.
LPS, IFN! and A" exposures induced an increase of nitrite levels
in MGC1 at 24 h and 48 h (Fig. 6A). In AEC-M1, nitrite release levels
were lower than in MGC1. A LPS treatment slightly increased the
production of nitrites after 24 h (2-fold), but not after 48 h. IFN! or
A" exposures did not promote nitrites production at both 24 and
48 h in AEC-M1.
An increase of PGE2 (Fig. 6B and C) and TNF$ release (Fig. 6D and
E) was observed in MGC1 after 24 h of LPS, IFN! and A" exposure. In
AEC-M1, the release of prostaglandins and TNF$ induced by a LPS
treatment was strongly lower (respectively −95% and −99%) than
in MGC1. An IFN! or A" exposure was unable to promote PGE2 and
TNF$ releases in AEC-M1.
In addition, secreted amounts of nitrite, PGE2 and TNF$ were
similar when cells were treated for 24 h with IFN! or A" in MGC1
or AEC-M1.
3.6. Time dependent effects of a microglial contamination
AEC-M1 were studied until 3 weeks after plating (Fig. 7). As
shown in Fig. 7A, the number of microglial cells increased from
7 to 21 days of culture. As previously described, the GFAP staining
was low at 7 days but higher after 21 days when microglial cells
(Iba1 staining) were also numerous. A 6 h LPS exposure (Fig. 7B)
increased Nos2, Ptgs2, Tnf and Il1" expression in a time depend-
ent manner. Thereby, the pro-inflammatory state was  higher after
21 days, which coincided with an elevated number of Iba1-positive
cells.
3.7. Comparison between single- and double-sorted glial cultures
MGC1 were also compared to twice-sorted glial cultures, called
AEC-M2 (Fig. 8). Itgam and Aif1 are genes coding respectively for the
two proteins CD11b and Iba-1, exclusively expressed in microglia
but not in astrocytes. AEC-M2 presented no Iba1-immunostaining
(Fig. 8A) as well as no detectable microglial markers (Itgam and
Aif1) mRNA expression (Fig. 8B). Compared to MGC1, AEC-M2
expressed lower GFAP expression levels (Fig. 8A and B). As a result
of the absence of microglial cells, a pro-inflammatory LPS exposure
had only minor effects on AEC-M2 and was  subsequently not able
to induce a real pro-inflammatory state (Fig. 8C).
4. Discussion
More than 35 years ago, Booher and Sensenbrenner developed in
vitro methods for brain cells cultures (Booher and Sensenbrenner,
1972). For decades, these methods have been used by the research
community. However, in the last few years, scientists have noticed
that, due to their high reactivity potential, microglial cell con-
tamination could alter the experimental response obtained from
primary astrocytic cultures. For the purification of glial cells, several
protocols are frequently found in the literature, like coating, sub-
culturing or shaking methods. To reduce the presence of microglia
or other contaminating cells, cytosine arabinoside, a specific toxin,
anti-mitotic or lysosomotropic agents can also be employed (Saura,
2007; Hamby et al., 2006a). The mechanical shake-off method is the
most widely used, which allows recovering microglial cells that are
present above the astroglial monolayer. However, with this proce-
dure, the exclusion of microglial cells from mixed glial cell cultures
is incomplete. Indeed, this shaking method appears to be inefficient
to remove microglial cells located below or inside the astroglial
monolayer.
Here, we have compared mouse MGC1 (twice shaken and
washed glial cultures), AEC-M1 (magnetic cell sorted cultures),
AEC-M2 (twice-sorted cultures), neurosphere-derived astrocyte
cultures and primary microglia cultures. From the mixed glial cul-
tures, magnetic cell separation allows a single-step isolation of
microglial cells (CD11b-positive fraction), but also AEC-M1 (CD11b-
negative fraction). In this study, these different types of culture
methods allowed us to evaluate the importance of the presence of
microglial cells in the establishment and analysis of an inflamma-
tory condition in glial cultures.
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The first part of this work aimed at determining the propor-
tion of microglia in MGC1 and AEC-M1. By immunocytochemistry,
we confirmed that Iba1-positive cells are present in mouse MGC1
even after two shaking and washing steps. Conversely, after CD11b
magnetic separation, the proportion of Iba1-positive cells in the
negative fraction, corresponding to the AEC-M1, was, as expected,
much lower than in mixed cultures. The immunostaining of the
glial fibrillary acidic protein (GFAP), an intermediate filament com-
ponent of astroglial cells (Bramanti et al., 2010; Röhl et al., 2007),
was slightly higher in MGC1 than in AEC-M1. GFAP is a tightly
regulated protein, whose expression is induced by multiple fac-
tors such as brain injury and diseases (Middeldorp and Hol, 2011).
Removing microglial cells from culture promoted a decrease of the
basal levels of secreted compounds like TNF$. Thus, a decrease
of the astrocytic reactivity related to a down-regulation of GFAP
expression was  subsequently observed. The amount of microglial
cells in glial cultures was accurately determined by flow cytom-
etry experiments. A CD11b magnetic separation decreased the
Iba1-positive cells from 9 to 10% in MGC1 to 1–1.5% in AEC-M1. Con-
sequently, the GFAP-positive cells increased from 60% in MGC1 to
70% in AEC-M1. These results are in accordance with recent assess-
ments of glial populations in cultures (Marek et al., 2008). Besides,
cells that were negative for microglial and astroglial markers in
both cultures were probably mainly precursors and differentiated
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Fig. 7. Time-dependent effect of a microglial contamination. AEC-M1 were cultured for 7, 14 and 21 days after CD11b-magnetic cell sorting. These cells were labeled
with  anti-GFAP antibody (red) in combination with the microglial marker Iba1 (green) and counterstained with nuclear stain DAPI (blue) at the different time points (A).
Pro-inflammatory gene Nos2, Ptgs2, Tnf and Il1" expressions (B) were also determined in these cultures after 6 h of LPS (1 #g/ml) exposure. The transcription levels were
analyzed by real-time PCR. Control expression levels were fixed at 1.0. All gene expressions were normalized to Rpl27 expression level. Results are given as mean ± SEM
(n  = 3 independent experiments). *p < 0.05, significantly different from control. (For interpretation of the references to color in this figure legend, the reader is referred to the
web  version of this article.)
oligodendrocytes, but also GFAP-negative astrocytes. In fact, it has
been reported that some astrocytes populations in healthy CNS do
not express, or express at low level, GFAP (Sofroniew and Vinters,
2010; Sofroniew, 2009; Buffo et al., 2008).
Microglia, the most reactive cells against pro-inflammatory
stimuli, detect and respond rapidly to pro-inflammatory triggers
(Lull and Block, 2010; Kim and Joh, 2006). Based on previous
papers, astrocyte-mediated effects are completely masked when
cultures contain a large population of microglia. For this reason,
we agree with the authors who have underlined the necessity
to minimize the proportion of microglial cells in glial cultures
(Marek et al., 2008; Saura, 2007; Hamby et al., 2006a,b; Hewett
et al., 1999). Thus, in this work, we have made a direct comparison
between cultures with a known percentage of microglia contam-
ination and cultures with minimal or no microglia. To induce an
inflammatory environment, we  treated our glial cultures with pro-
inflammatory compounds, known to promote cellular activation
by distinct biological pathways. Thus, we have used a nuclear
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Fig. 8. Comparison of MGC1 with AEC-M2. Both glial cells cultures were labeled with anti-GFAP antibody (red) in combination with the microglial marker Iba1 (green) and
counterstained with nuclear stain DAPI (blue) (A). Transcription levels and Ct values of the astrocytic marker (Gfap) as well as microglial markers (Itgam and Aif1) were
evaluated by real-time PCR in control condition in both glial cultures (B). Cultures were also treated with LPS (1 #g/ml) for 6 h. The transcription levels of the pro-inflammatory
genes  Nos2, Ptgs2, Tnf and Il1" were analyzed by real-time PCR (C). Control expression levels were fixed at 1.0. All gene expressions were normalized to Rpl27 expression
level.  Results are given as mean ± SEM (n = 3 independent experiments). (For interpretation of the references to color in this figure legend, the reader is referred to the web
version of this article.)
factor kappa B (NF%B) pathway-inducer (LPS) (Carmody and Chen,
2007), a janus kinase-signal transducer and activator of transcrip-
tion (JAK-STAT) pathway-inducer (IFN!) (Gough et al., 2008) as
well as the beta-amyloid peptide (1–42) (A")  in an oligomeric
conformation (Heurtaux et al., 2010). In recent studies, we  have
demonstrated that LPS, IFN!, as well as the oligomeric form of the
A" peptide were able to strongly activate microglial cells (Heurtaux
et al., 2010; Michelucci et al., 2009). At the transcriptional level,
we have observed that 6 h of LPS exposure in MGC1 induced a
higher pro-inflammatory state than an IFN! or A" exposure. This
pro-inflammatory status appeared to be lower in AEC-M1 where
microglial cells were almost absent. In these AEC-M1, a 6 h A"
exposure was  unable to up-regulate Nos2, Ptgs2 and Tnf mRNA
expression and only slightly induced Il1" and Il6 expression. Thus,
a short single A" treatment had poor effects on AEC-M1 activa-
tion. In addition, as a result of gene expression modulation, we
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have also observed that pro-inflammatory mediators (nitrites, PGE2
and TNF$) releases were strongly decreased in AEC-M1 compared
to MGC1 both treated with either LPS, IFN! or A". Interestingly,
results obtained with A" clearly showed that a short treatment
was unable to activate AEC-M1. This is in accordance with a
recent study (Ebenezer et al., 2010). In this work, we have used
an oligomeric A" preparation, which is known to strongly acti-
vate microglial cells. These results support the hypothesis that
activation of astrocytes around A" deposits in Alzheimer’s dis-
ease may  be due to prior microglial activation inducing finally a
chronic inflammatory state. It is well documented that activated
microglia represent a major source of inflammatory factors. In this
study, we have described that primary microglia strongly reacted
to LPS exposure (Table 3). The presence of IFN! or A" peptide
also induced a pro-inflammatory phenotype in primary microglial
cells. Microglia appeared to be more sensitive to LPS, IFN! and
A" treatments than AEC-M1 and MGC1. The strong up-regulation
of the pro-inflammatory genes underlined the importance of a
microglial contamination even if the percentage of these cells
is lower than 10% of the total cells in culture. Thus, to confirm
the importance of microglia in the initiation of an inflammatory
environment, we have also realized a control by using cultures
devoid of microglial cells. These microglia-free astrocyte cultures
were obtained after differentiation of neurospheres (Crocker et al.,
2008). Challenging these cultures with either LPS, IFN! or A"
had only little effect on the up-regulation of pro-inflammatory
genes. With the exception of LPS treatment, which is a strong
microglial activator, the inflammatory response in AEC-M1 and
neurosphere-derived pure astrocyte cultures are obviously very
closed. Thus, both cultures represent similar in vitro models for
astrocyte studies. These results are in accordance with published
work (Crocker et al., 2008). In the same way, Hamby et al. (2006a)
reported a method for eradicating microglia from primary glial cul-
tures. The authors treated confluent astrocyte monolayers with a
mitotic inhibitor (cytosine "-d-arabinofuranoside) followed by a
brief exposure to high concentrations of a lysosomotrophic agent
(l-leucine methyl ester, LME). By this method, they generated
highly purified astrocytes without the need for cell passage. Their
results are quite similar to our results and confirm the necessity to
eliminate microglia from glial cultures. However, this method using
the LME  lysosomotrophic agent only permits to obtain near-pure
astrocyte cultures when our magnetic separation permits to obtain
rapidly both near-pure astrocyte cultures and pure microglial
cultures.
Bacterial endotoxin receptors, mainly Toll-like receptor 4
(TLR4), are implicated in LPS bioactivity (Peri et al., 2010). However,
in these neurosphere-derived astrocytes, the LPS-TLR4 signaling
pathway does not seem to be operational. This observation could
be linked to the low level of TLR4 expression in astrocytes (Mishra
et al., 2006; Jack et al., 2005). TLR4 receptor is documented to
be present on circulating monocytes, macrophages and other sys-
temic immune cells. We have also demonstrated that microglia
strongly express TLR4 whereas astrocytes do not express it (data
not shown). These data are in accordance with a previous work
(Lehnardt et al., 2002). Moreover, due to the high TLR4 expression
level in microglia (Buchanan et al., 2010; Mishra et al., 2006; Jack
et al., 2005), treating glial cultures with LPS could represent a way
to confirm their presence. Furthermore, the basal expression levels
of pro-inflammatory genes (Tnf, Il1" and Ccl3), as well as those of
specific microglial markers (Itgam and Aif1) are higher in primary
microglia than in MGC1 (Table 2). In AEC-M1 and in neurosphere-
derived astrocytes, the expression levels are even lower (threshold
cycle Ct > 30). According to these data, the level of microglial cell
contamination could also be evaluated by a simple comparison of
the threshold cycle of these pro-inflammatory genes or microglial
markers in basal conditions in cultures.
We  have also described time-dependent effects of a microglial
contamination. AEC-M1 were studied up until 3 weeks after plating.
The percentage of Iba1-positive cells increased in a time depend-
ent manner in these non-treated confluent glial cultures. Possibly
as a result of the increased number of microglia, the GFAP expres-
sion level was  also enhanced. This is in accordance with our
observations, where we described that astrocytic reactivity and
GFAP expression were increased in the presence of microglial cells
(Fig. 2). Moreover, a LPS exposure induced a time dependent pro-
inflammatory state, which was  higher after 3 weeks of culture,
and coincided with the presence of a high number of contaminat-
ing microglial cells. Finally, we  have compared MGC1 and AEC-M2
(twice-sorted glial cultures). The AEC-M2 presented a lower GFAP
expression level and no detectable microglial markers expression.
Furthermore, a LPS exposure was  not able to induce a real pro-
inflammatory state, thus confirming the absence of microglial cells
with this culturing procedure.
In our conditions, we  clearly show that microglia-depleted
cultures (AEC-M1/M2 and neurosphere-derived astrocytes) are
weakly activated by pro-inflammatory agents. The presence of
microglia appears to be crucial in the establishment of an inflam-
matory state. There is growing interest about the role of glial
cells in neurodegenerative pathologies (Amor et al., 2010; Hamby
and Sofroniew, 2010; Perry et al., 2010). On one hand, the iso-
lation of glial cells allows studying the responsiveness of each
cell type to pro-inflammatory agents. On the other hand, the use
of mixed cultures could reflect the physiological condition and
could be useful to observe global modifications and cellular inter-
actions characterizing CNS disorders. Microglial cells rapidly and
strongly react to brain insults. Due to their high reactivity to various
aggressions or pro-inflammatory stimuli, microglia-derived effects
might be credited to astrocytes in mixed cultures. In these con-
ditions, the subsequent reactive astrocytes interact in a complex
manner with microglia and can exert pro-inflammatory but also
anti-inflammatory effects (Fuller et al., 2010; Zhang et al., 2010).
In conclusion, our results suggest the necessity to rigorously
check the purity of glial cultures. Attention should be paid to the
presence of microglia in glial cultures because of their potential
alteration of the results, especially when inflammatory processes
are investigated. For that reason, the magnetic cell sorting technol-
ogy appears to be an efficient and rapid method to limit microglial
contamination in glial cultures. In addition, it allows to rapidly
obtain near-pure astrocyte cultures but also pure microglial cul-
tures.
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